Canadian Phase Onward

Toronto M3J 0K2

2 studies enrolling now · 3 studies all time

What they study most

Constipation, Diarrhea, Irritable Bowel Syndrome, Obesity, Overweight

Studies at this site

• A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D) — Recruiting now
• A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C) — Recruiting now
• A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight — Running, not enrolling